Evidence map›Paper›PMID 33084974›Full record

ArticleFamilial cancer2021

A novel germline variant in RET gene resulting in an additional cysteine in a family with familial medullary thyroid carcinoma.

Josep Oriola, Aurora Sanchez, Blanca Paniello, Jordi Puig de la Bellacasa, Josefina Biarnés

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Familial cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 80% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Genes · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Josep OriolaServei de Bioquímica i Genètica Molecular, CDB, Hospital Clínic, Barcelona, Spain. joriola@clinic.cat.
Aurora SanchezServei de Bioquímica i Genètica Molecular, CDB, Hospital Clínic, Barcelona, Spain.
Blanca PanielloServei de Bioquímica i Genètica Molecular, CDB, Hospital Clínic, Barcelona, Spain.
Jordi Puig de la BellacasaServei d'Endocrinologia i Nutrició, IDIBELL, Hospital Universitari de Bellvitge, Barcelona, Spain.
Josefina BiarnésDiabetis i Nutrició (UDENTG), Unitat d'Endocrinologia, CIBEROBN,Hospital Universitari Dr. Josep Trueta, Girona, Spain.
Hospital Universitari de Girona Doctor Josep Trueta · ESInstitut d'Investigació Biomédica de Bellvitge · ESUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant inherited disease, characterized by germ-line variants in RET proto-oncogene. Variants are frequently located in the RET extracellular cysteine-rich region domain, mainly affecting cysteines which are replaced by an alternative amino acid, resulting in a mispaired cysteine and the generation of RET dimers. We describe a novel c.1765A > T variant of RET proto-oncogene in a family with medullary thyroid carcinoma (MTC) that predicts the creation of an additional cysteine p.(Ser589Cys) in the cysteine-rich domain. In this site only three other punctual variants have been described, giving rise to extra cysteines. We have characterized the clinical phenotype of this family. The index case was a 79-year-old woman with MTC in both thyroid lobes. This variant co-segregates in this family in four affected members. One member was operated on at 31 years of age and already presented MTC, indicating that prophylactic thyroidectomy was appropriated. Variants predicting additional cysteines are not frequent in RET, and when present, they allow us to understand their implication in the disease. According to clinical data obtained in this family, this variant could be categorized as a moderate-risk of the disease.

Indexed as

CysteineGerm-Line MutationAdultAgedCarcinoma, MedullaryFemaleHeterozygoteHumansMaleMiddle AgedMultiple Endocrine Neoplasia Type 2aPedigreePhenotypeProphylactic Surgical ProceduresProto-Oncogene Proteins c-retThyroidectomyCysteineProto-Oncogene Proteins c-retRET protein, humanCancerEndocrineMedullary thyroid carcinomaRET proto-oncogene

Identifiers

PMID33084974
OpenAlexW3094466493

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.